Skip to content

Clinical study of laryngeal mask general anesthesia with ciprofol combined with oliceridine in fibrobronchoscopy

Clinical study of laryngeal mask general anesthesia with ciprofol combined with oliceridine in fibrobronchoscopy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088652
Enrollment
Unknown
Registered
2024-08-23
Start date
2024-08-31
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiration

Interventions

Oliceridine group:Anesthesia induction with oliceridine followed by ciprofol.
Fentanyl group:Anesthesia induction with fentanyl followed by ciprofol.

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65; 2. ASA1-III; 3. Patients undergo fibrobronchoscopy under general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications for bronchoscopy; 2. Patients with difficult airway; 3. Patients with study drug allergy; 4, patients with severe hypertension (systolic blood pressure =180mmHg, or diastolic blood pressure =110mmHg); 5. Patients with severe arrhythmia; 6. Patients with severe cardiac insufficiency classified as New York Heart Association (NYHA) Level III or above; 7. Patients with liver and kidney dysfunction characterized by abnormal biochemical indexes of liver and kidney function; 8. Patients whose preoperative state of consciousness is difficult to determine; 9. Patients with a history of psychotropic drug use; 10. Patients who meet any other conditions that the investigators deem unsuitable for inclusion in this study.

Design outcomes

Primary

MeasureTime frame
Tracheal response rate during bronchoscopy examination;Respiratory depression rate during bronchoscop;

Secondary

MeasureTime frame
Dose of vasoactive drugs;Dose of anesthesia;Time of surgery and anesthesia;Patient comfort level;Operator comfort level;Vital signs(blood pressure, HR, SpO2, RR, BIS);Completion of FOB;

Countries

China

Contacts

Public ContactXuehai Guan

The First Affiliated Hospital of Guangxi Medical University

guan_xh@aliyun.com+86 185 8769 7310

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026